Vanguard Global Advisers
AIFF

Vanguard Global Advisers’s Firefly Neuroscience AIFF Stock Holding History

Vanguard Global Advisers’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.35K Hold
2,768
– – ﹤0.01% 3582
2026
Q1 		$6.03K Buy
+2,768
New +$3.45K ﹤0.01% 3542

Other funds holding AIFF

M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Vanguard Global Advisers's AIFF Position: Q2 2026 in Review

Vanguard Global Advisers held its Firefly Neuroscience (AIFF) position steady in Q2 2026 at 2,768 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

Vanguard Global Advisers first reported a position in AIFF in Q1 2026 and has held it in 2 quarters since. The position peaked at $6.03K in Q1 2026. 21 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.

  • Vanguard Global Advisers held 2,768 shares of Firefly Neuroscience worth $3.35K as of Q2 2026.
  • Vanguard Global Advisers left its Firefly Neuroscience share count unchanged in Q2 2026.
  • Firefly Neuroscience made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #3582 holding.
  • Vanguard Global Advisers first reported a position in Firefly Neuroscience in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Global Advisers's Firefly Neuroscience position peaked at $6.03K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.